The Breakthrough ALS fundraising campaign was established in 2013 by the ALS Therapy Alliance (ATA) to replace their successful Researching a Cure campaign, which ran for 11 years.
The new campaign name is a bold call to action for raising funds and creating awareness of Amyotrophic Lateral Sclerosis (ALS). ALS is a nerve disorder that leads to paralysis and death within four to six years, and will afflict between 300,000 to 750,000 Americans alive today. There is no cure and the cause is unknown.
Through fundraising and partnership efforts - including a partnership with CVS/pharmacy the largest corporate donor to ALS research in the U.S. - over the last decade, the ATA has raised over $30 million for ALS research.
The ATA is committed to creating awareness of this disease, fundraising with its strategic partners and galvanizing communities of people to help make a difference.